Intchains Group
ICG
IREN Ltd
IREN
Bit Origin
BTOG
BTCS Inc
BTCS
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
RLAY Relay Therapeutics
- 4.450
- -0.380-7.87%
Close Jan 10 16:00 ET
- 4.400
- -0.050-1.12%
Post 20:01 ET
744.85MMarket Cap-1.70P/E (TTM)
5.990High4.000Low11.85MVolume4.660Open4.830Pre Close56.62MTurnover9.30%Turnover RatioLossP/E (Static)167.38MShares11.16052wk High0.89P/B567.15MFloat Cap4.00052wk Low--Dividend TTM127.45MShs Float64.370Historical High--Div YieldTTM41.20%Amplitude4.000Historical Low4.776Avg Price1Lot Size
About Relay Therapeutics Company
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Company Profile
SymbolRLAY
Company NameRelay Therapeutics
Listing DateJul 16, 2020
Issue Price20.00
Founded2015
CEODr. Sanjiv K. Patel, M.B.B.S.,M.D.
MarketNASDAQ
Employees323
Fiscal Year Ends12-31
Address399 Binney Street,2nd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-370-8837
Websitehttp://www.relaytx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sanjiv K. Patel, M.B.B.S.,M.D.
- Director, President and Chief Executive Officer
- 19.77M
- Thomas Catinazzo
- Chief Financial Officer and Principal Accounting Officer
- 5.22M
- Brian R. Adams
- Chief Legal Officer and Secretary
- 4.51M
- Peter Rahmer
- Chief Corporate Development Officer
- 6.78M
- Dr. Donald A. Bergstrom, M.D.,PhD
- President, Research and Development
- 8.57M
- Dr. Laura Shawver, PhD
- Independent Director
- 551.14K
- Jami Rubin
- Independent Director
- 558.64K
- Dr. Mark Murcko, PhD
- Independent Director
- 548.64K
- Dr. Linda A. Hill,PhD
- Independent Director
- 551.14K
- Douglas S. Ingram,Esq.
- Independent Director
- 548.64K
- Dr. Sekar Kathiresan, M.D.
- Independent Director
- 538.64K
- Alexis A. Borisy, A.M.
- Chairperson of the Board
- 581.14K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.